P3 Health Partners Inc (PIII) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PIII Annual Cash Flow →
The quarterly cash flow data below helps track how P3 Health Partners Inc's liquidity profile has evolved over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income17.79
Depreciation & amortization42.12
Amortization of Other Assets44.60
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.13
Share-based Compensation1.92
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction30.75
Mark To Market Adjustment Of Stock Warrants-
Premium Deficiency Testing Expense Long Duration Contract Amount-4.72
Increase Decrease In Health Plan Receivables Premiums-32.44
Net Change In Rights Of Use Assets And Liabilities-
Increase Decrease In Health Plan Payables Premiums-21.59
Increase Decrease In Clinic Fees Insurance And Other Receivables-5.68
Increase Decrease In Accrued Payroll-
Increase Decrease In Insurance Settlements Payable-
Increase Decrease In Claims Payables-
Accretion Of Contingent Consideration-
Increase Decrease In Operating Lease Liability-0.13
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities0.47
Increase (Decrease) in Accounts Payable and Accrued Liabilities-3.60
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets9.19
Other Working Capital-5.04
Other Noncash Income (Expense)0.00
Other net10.02
Payments for (Proceeds from) Other Operating Activities-237.47
Discontinued operations0.00
Net Cash flow from Operating Activities-89.38
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for (Proceeds from) Loans Receivable, Total0.00
Payments for (Proceeds from) Other Investing Activities-0.25
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.25
Financing Activities
Short-term debt Net1.04
Other borrowing transactions-0.03
Long-term debt - borrowings27.00
Long-term debt - repayments-0.63
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock58.64
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment For Loan Origination And Closing Fees-
Deferred Offering Costs Paid-
Proceeds From Issuance Of Common Stock Net Of Offering Cost-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents25.81
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities86.02
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-89.38
Total Cash Flow-3.61
4 historic quarters locked

Sign in to unlock the full P3 Health Partners Inc cash flow history.

About P3 Health Partners Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001832511-26-000034

Figures are derived from filed reports and may be restated. Historical data is subject to revision.